
CAS 1448221-05-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Vanucizumab
CAS :<p>Humanized bispecific IgG1 monoclonal antibody targeting the vascular endothelial growth factor receptor (VEGFR) ligand VEGF-A and the Tie2 receptor ligand angiopoietin-2 (Ang-2)</p>Vanucizumab
CAS :<p>Vanucizumab is a bispecific humanised monoclonal antibody that simultaneously inhibits the receptor interactions of VEGF-A and Angiopoietin-2 (Ang-2)</p>Degré de pureté :95%Couleur et forme :Liquid


